Related content

Model-based approaches to predict drug–drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond

By Barton Hugh A   Lai Yurong   Goosen Theunis C   Jones Hannah M   El-Kattan Ayman F   Gosset James R   Lin Jian   Varma Manthena V  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 459-472

Informa Healthcare

Access to resources Recommend Favorite

The Impact of In Vitro Binding on In Vitro - In Vivo Extrapolations, Projections of Metabolic Clearance and Clinical Drug-Drug Interactions

By  

Current Drug Metabolism, Vol. 7, Iss. 3, 2006-04 ,pp. : 251-264

Bentham Science Publishers

Access to resources Recommend Favorite

Maraviroc potential drug-drug interactions

By  

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Drug Interactions with Grapefruit Juice: Extent, Probable Mechanism and Clinical Relevance

By Fuhr U.  

Drug Safety, Vol. 18, Iss. 4, 1998-04 ,pp. : 251-272

Adis International

Access to resources Recommend Favorite

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

By Kostapanos Michael S.   Milionis Haralampos J.   Elisaf Moses S.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 11-28

Adis International

Access to resources Recommend Favorite